PL2683719T3 - PODSTAWIONE POCHODNE KWASU [(5H-PIROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YLO)PIPERAZYN-1-YLO]-2,2-DIMETYLOPROPANOWEGO JAKO ODWROTNI AGONIŚCI H1/ANTAGONIŚCI 5-HT2A O PODWÓJNYM DZIAŁANIU - Google Patents
PODSTAWIONE POCHODNE KWASU [(5H-PIROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YLO)PIPERAZYN-1-YLO]-2,2-DIMETYLOPROPANOWEGO JAKO ODWROTNI AGONIŚCI H1/ANTAGONIŚCI 5-HT2A O PODWÓJNYM DZIAŁANIUInfo
- Publication number
- PL2683719T3 PL2683719T3 PL12701824T PL12701824T PL2683719T3 PL 2683719 T3 PL2683719 T3 PL 2683719T3 PL 12701824 T PL12701824 T PL 12701824T PL 12701824 T PL12701824 T PL 12701824T PL 2683719 T3 PL2683719 T3 PL 2683719T3
- Authority
- PL
- Poland
- Prior art keywords
- benzodiazepin
- piperazin
- pyrrolo
- substituted
- acid compounds
- Prior art date
Links
- BTWFSNJLQVPVHF-UHFFFAOYSA-N 2,2-dimethyl-3-[2-(11h-pyrrolo[2,1-c][1,4]benzodiazepin-6-yl)piperazin-1-yl]propanoic acid Chemical class OC(=O)C(C)(C)CN1CCNCC1C1=NC2=CC=CC=C2CN2C1=CC=C2 BTWFSNJLQVPVHF-UHFFFAOYSA-N 0.000 title 1
- 102100036321 5-hydroxytryptamine receptor 2A Human genes 0.000 title 1
- 101710138091 5-hydroxytryptamine receptor 2A Proteins 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 230000009977 dual effect Effects 0.000 title 1
- 238000003874 inverse correlation nuclear magnetic resonance spectroscopy Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161440092P | 2011-02-07 | 2011-02-07 | |
| PCT/US2012/022455 WO2012109011A1 (en) | 2011-02-07 | 2012-01-25 | SUBSTITUTED [(5H-PYRROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
| EP12701824.0A EP2683719B1 (en) | 2011-02-07 | 2012-01-25 | SUBSTITUTED [(5H-PYRROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2683719T3 true PL2683719T3 (pl) | 2015-08-31 |
Family
ID=45558426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12701824T PL2683719T3 (pl) | 2011-02-07 | 2012-01-25 | PODSTAWIONE POCHODNE KWASU [(5H-PIROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YLO)PIPERAZYN-1-YLO]-2,2-DIMETYLOPROPANOWEGO JAKO ODWROTNI AGONIŚCI H1/ANTAGONIŚCI 5-HT2A O PODWÓJNYM DZIAŁANIU |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8314092B2 (pl) |
| EP (1) | EP2683719B1 (pl) |
| JP (1) | JP5805215B2 (pl) |
| KR (1) | KR101549315B1 (pl) |
| CN (1) | CN103391940B (pl) |
| AR (1) | AR084867A1 (pl) |
| AU (1) | AU2012214788B2 (pl) |
| BR (1) | BR112013019996A2 (pl) |
| CA (1) | CA2826757C (pl) |
| CY (1) | CY1116206T1 (pl) |
| DK (1) | DK2683719T3 (pl) |
| EA (1) | EA022708B1 (pl) |
| ES (1) | ES2539502T3 (pl) |
| HR (1) | HRP20150469T1 (pl) |
| MX (1) | MX2013008786A (pl) |
| PL (1) | PL2683719T3 (pl) |
| PT (1) | PT2683719E (pl) |
| RS (1) | RS54001B1 (pl) |
| SI (1) | SI2683719T1 (pl) |
| TW (1) | TWI564300B (pl) |
| WO (1) | WO2012109011A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2729474T3 (pl) * | 2011-07-08 | 2018-08-11 | ||
| HUE037363T2 (hu) * | 2013-01-14 | 2018-08-28 | Lilly Co Eli | Kettõs aktivitású H1 inverz agonista/5-HT2A antagonista (tieno[2,3-b][1,5]-benzoxazepin-4-il)piperazin-1-il vegyületek |
| CN114929688B (zh) * | 2019-10-21 | 2024-11-01 | 阿莱瑞恩公司 | 作为H1和5-HT2A-受体调节剂、用于治疗睡眠障碍的3-(4-(11H-二苯并[b,e][1,4]吖庚英-6-基)哌嗪-1-基)-和3-(4-(二苯并[b,f][1,4]氧杂吖庚英/硫杂吖庚英/二吖庚英-11-基)哌嗪-1-基)-丙酸衍生物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4192803A (en) * | 1978-09-15 | 1980-03-11 | American Cyanamid Company | 5H-Pyrrolo[2,1-c][1,4]benzodiazepine derivatives |
| US4460587A (en) * | 1981-12-07 | 1984-07-17 | Ciba-Geigy Corporation | 5-Diazacycloalkyl imidazo[1,2-c][1,3]benzodiazepines |
| US4507311A (en) | 1981-12-07 | 1985-03-26 | Ciba-Geigy Corporation | Imidazo[1,2-c][1,3]benzodiazepines |
| US4596799A (en) | 1985-01-29 | 1986-06-24 | Ciba-Geigy Corporation | 9H-pyrrolo[2,1-c]-1,2,4-triazolo[4,3-a][1,4]benzodiazepines |
| US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| US20090023721A1 (en) * | 2005-05-26 | 2009-01-22 | Megens Antonius Adrianus Hendr | Novel Substituted Tetracyclic Tetrahydrofuran, Pyrrolidine and Tetrahydrothiophene Derivatives and Their Use as a Medicament |
| US7807828B2 (en) * | 2005-08-11 | 2010-10-05 | Hypnion, Inc. | Olanzapine analogs and methods of use thereof |
| GB0910009D0 (en) | 2009-06-10 | 2009-07-22 | Glaxo Group Ltd | Novel compounds |
-
2012
- 2012-01-16 AR ARP120100144A patent/AR084867A1/es unknown
- 2012-01-20 TW TW101102371A patent/TWI564300B/zh not_active IP Right Cessation
- 2012-01-25 PT PT127018240T patent/PT2683719E/pt unknown
- 2012-01-25 US US13/357,627 patent/US8314092B2/en active Active
- 2012-01-25 KR KR1020137020744A patent/KR101549315B1/ko not_active Expired - Fee Related
- 2012-01-25 EP EP12701824.0A patent/EP2683719B1/en active Active
- 2012-01-25 JP JP2013552554A patent/JP5805215B2/ja active Active
- 2012-01-25 AU AU2012214788A patent/AU2012214788B2/en not_active Ceased
- 2012-01-25 CN CN201280008068.3A patent/CN103391940B/zh active Active
- 2012-01-25 DK DK12701824T patent/DK2683719T3/en active
- 2012-01-25 WO PCT/US2012/022455 patent/WO2012109011A1/en not_active Ceased
- 2012-01-25 BR BR112013019996A patent/BR112013019996A2/pt not_active Application Discontinuation
- 2012-01-25 CA CA2826757A patent/CA2826757C/en not_active Expired - Fee Related
- 2012-01-25 MX MX2013008786A patent/MX2013008786A/es active IP Right Grant
- 2012-01-25 ES ES12701824.0T patent/ES2539502T3/es active Active
- 2012-01-25 SI SI201230159T patent/SI2683719T1/sl unknown
- 2012-01-25 RS RS20150323A patent/RS54001B1/sr unknown
- 2012-01-25 HR HRP20150469TT patent/HRP20150469T1/hr unknown
- 2012-01-25 EA EA201390966A patent/EA022708B1/ru not_active IP Right Cessation
- 2012-01-25 PL PL12701824T patent/PL2683719T3/pl unknown
-
2015
- 2015-04-17 CY CY20151100361T patent/CY1116206T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2826757A1 (en) | 2012-08-16 |
| RS54001B1 (sr) | 2015-10-30 |
| EP2683719A1 (en) | 2014-01-15 |
| JP5805215B2 (ja) | 2015-11-04 |
| DK2683719T3 (en) | 2015-04-27 |
| US8314092B2 (en) | 2012-11-20 |
| BR112013019996A2 (pt) | 2018-07-24 |
| AU2012214788A1 (en) | 2013-07-11 |
| HRP20150469T1 (hr) | 2015-06-05 |
| US20120202797A1 (en) | 2012-08-09 |
| AR084867A1 (es) | 2013-07-10 |
| EP2683719B1 (en) | 2015-03-18 |
| MX2013008786A (es) | 2013-09-06 |
| WO2012109011A1 (en) | 2012-08-16 |
| KR101549315B1 (ko) | 2015-09-01 |
| EA022708B1 (ru) | 2016-02-29 |
| ES2539502T3 (es) | 2015-07-01 |
| AU2012214788B2 (en) | 2014-10-02 |
| CA2826757C (en) | 2015-05-26 |
| TWI564300B (zh) | 2017-01-01 |
| PT2683719E (pt) | 2015-06-05 |
| CY1116206T1 (el) | 2017-02-08 |
| CN103391940B (zh) | 2015-08-26 |
| CN103391940A (zh) | 2013-11-13 |
| EA201390966A1 (ru) | 2013-12-30 |
| TW201245197A (en) | 2012-11-16 |
| KR20130103617A (ko) | 2013-09-23 |
| JP2014504637A (ja) | 2014-02-24 |
| SI2683719T1 (sl) | 2015-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201206440B (en) | [5,6]heterocyclic compound | |
| SG11201402197UA (en) | [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 | |
| IL233067B (en) | History of 3-(((alkyl)sulfonyl)carbamoyl)-5-pyrrolidin-1-yl-pyrazolo[a-1,5]pyridine as tropomyosin kinase receptor inhibitors | |
| ZA201400874B (en) | (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS | |
| EP2661437A4 (en) | 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO [2,3] PYRIMIDINE DERIVATIVES AS FAK / PYK2 INHIBITORS | |
| AP2012006313A0 (en) | Pyrazole compounds as CRTH2 antagonists. | |
| EP2699091A4 (en) | 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS | |
| SG11201401907TA (en) | Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof | |
| IL232304A (en) | [3,2,1] triazolo [5,4– d] pyrimidine derivatives as cannabinoid receptor type 2 agonists [3,2,1] triazolo [5,4– d] pyrimidine as cannabinoid receptor 2 agonists | |
| IL212179A0 (en) | Nitrogenous heterocyclic compounds, preparation thereof, and use thereof as antibacterial agents | |
| IL232916A0 (en) | History of 6-difluoromethyl-6,5-dihydro-h2[4,1]oxazin-3-amine | |
| EP2657244B8 (en) | Glycoside compounds as glp-1 secretion promoting agents | |
| PT2683719E (pt) | Compostos de ácido [(5h-pirrolo[2,1-c][1,4]benzodiazepin- 11-il)piperazin-1-il]-2,2-dimetil-propanoico substituído utilizados enquanto agonistas inversos de h1/antagonistas de 5-ht2a com dupla atividade | |
| PL2729474T3 (pl) | Związki (tieno[2,3-b][1,5]benzoksazepin-ylo)piperazyn-ylowe jako odwrotne agonisty H1/antagonisty 5-HT<sub>2A</sub> o podwójnej aktywności | |
| IL218764A (en) | Crystalline lupilopinic acid and the process for its preparation, its uses, and its pharmaceutical preparations | |
| ZA201504041B (en) | (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists | |
| UA62458U (en) | 7'-SUBSTITUTED-1-(4-CHLOROPHENYL)-3',7'-DIHYDRO-2H,2'H,5H-SPIRO[PYRROLIDINE-3,6'-THIOPYRANO[2,3-d][1.3]THIAZOL]-2,2',5-TRIONES, EXHIBITING ANTITRYPANOSOMAL ACTIVITY |